Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Allott, Emma H.; Ambrosone, Christine B.; Bell, Mary B.; Bethea, Traci N.; Bshara, Wiam; Cohen, Stephanie M.; Geradts, Joseph; Hu, Zhiyuan; Hwang, Helena; Khoury, Thaer; Kirk, Erin L.; Li, Yan; Miller, C. Ryan; O'Connor, Siobhan; Olshan, Andrew F.; Palmer, Julie R.; Perou, Charles M.; Sun, Xuezheng; Thorne, Leigh B.; Troester, Melissa A.; Tse, Chiu-Kit; Zirpoli, Gary R.

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Abstract

Classification of breast cancer into intrinsic subtypes has clinical and epidemiologic importance. To examine accuracy of immunohistochemistry (IHC)-based methods for identifying intrinsic subtypes, a three-biomarker IHC panel was compared to the clinical record and RNA-based intrinsic (PAM50) subtypes

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

Carolina Digital Repository

cdr.lib.unc.edu:zc77sv97n

Last time updated on 23/04/2020